Statement showing un-audited Financial results for the quarter ended 30.06.2025 along with Limited Review Report.

Revenue declinedNet loss reportedEBITDA margin compressionResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-11.7%Reaction day

₹47.68

prior close

₹47.55

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%-11.7% vs market

Pharmaceuticals peers, median of 151sector+0.0%-11.7% vs sector

On the reaction day the stock moved 11.7 pts less than Nifty Microcap 250 and 11.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.9

10m

+0.9

15m

+0.9

30m

-2.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-11.7+0.0-11.7+0.0-11.7

Next day

-10.9+0.7-11.5+0.1-11.0

-13.0-0.1-12.8-0.1-12.8

-13.4+1.4-14.8+0.5-13.8

-8.9+2.6-11.5+0.4-9.2

-9.4+2.5-11.9+0.4-9.8

-5.6+2.2-7.9+1.0-6.7

15d

-15.1+1.9-17.0-0.4-14.6

-16.1+2.8-18.9+1.7-17.8

+19.5+1.2+18.3-1.7+21.3

-7.7+2.2-9.9-3.2-4.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Gujarat Terce Laboratories reported revenue from operations of Rs. 1,085.36 lakhs for Q1 FY26, down from Rs. 1,188.88 lakhs in Q1 FY25, an 8.7% year-on-year decline. The company posted a loss before tax of Rs. 7.10 lakhs, marginally better than the Rs. 6.94 lakh loss a year ago. After a deferred tax credit of Rs. 2.75 lakhs, net loss came in at Rs. 4.35 lakhs versus Rs. 7.76 lakhs in Q1 FY25. Basic EPS was Rs. -0.06 versus Rs. -0.10 previously. The full-year FY25 had ended with a much larger loss of Rs. 97.87 lakhs on revenue of Rs. 5,019.52 lakhs. The statutory auditor M. A. Shah & Co. issued an unmodified limited review report with no qualifications or emphasis-of-matter paragraphs.

Likely market impact

Despite the revenue dip, the company narrowed its quarterly loss slightly, but weak operating margins and continued losses mean the stock remains under pressure with no near-term profit visibility for shareholders.